HALO
Halozyme Therape (HALO)
NASDAQ
$113.00+$0.55 (+0.49%)
Price as of Sep 18, 2026 7:56 PM EDT
  • $12.8B
    Market Cap
  • 44.52%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 63
Valuation
HALO
vs History
vs S&P 500
Profitability
0
Growth
-0
Low Earnings Volatility
1

Momentum Score

Score: 89
Valuation
HALO
vs History
vs S&P 500
3-Month Momentum
54.54%
12-Month Momentum
40.35%
3-Month Risk Adjusted Momentum
238.76%
12-Month Risk Adjusted Momentum
110.31%

True Yield

N/A
Valuation
HALO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.42%
Net Debt Paydown Yield
-0.03%

Financial Health Score

Score: 38
Valuation
HALO
vs History
vs S&P 500
Ohlson's O-Score
6